Bisomni 2.5 vs Bisomni 5: Choosing the Strength

Four related products often come up in the same conversation, so it helps to see what is actually inside each one.

The first two share a molecule and differ only in strength. The Metomni-XL products use a different beta-blocker, metoprolol succinate, formulated as an extended-release tablet so the medicine is released gradually through the day.

All four are Schedule H prescription medicines marketed by EMK Omni Pharma and dispensed only against a doctor's prescription. None of them is a substitute for another chosen at the counter.

The difference between these two is the amount of bisoprolol fumarate per tablet: 2.5 mg against 5 mg. Everything else about the molecule is the same.

Doctors often begin at the lower strength, particularly in older patients, in people whose resting pulse is already on the slower side, where kidney or liver function is reduced, or in chronic heart failure where a specialist raises the strength in careful steps over weeks while watching symptoms, weight and pulse at each stage.

The higher strength may be chosen when the lower one has been tolerated but has not brought the blood pressure or heart rate to the target your doctor set. The move is made by the doctor, based on measurements, not on how you feel on a given morning.

Do not attempt to convert one into the other. Splitting or doubling tablets to improvise a strength changes the dose in an uncontrolled way and can leave the pulse too slow or the pressure too high.

Bisomni and Metomni-XL are not different sizes of the same thing. They are different medicines.

Both bisoprolol and metoprolol are beta-1 selective blockers, so they share a general approach: settle the heart rate, reduce cardiac workload, lower blood pressure. They differ in how selective they are, how the body clears them and how the tablet is built. Metoprolol succinate in Metomni-XL is an extended-release formulation, designed to release the molecule slowly so one tablet covers the day. Bisoprolol is long-acting by nature of the molecule itself.

Clearance differs too. Bisoprolol is handled roughly half by the kidneys and half by the liver, while metoprolol depends more heavily on liver metabolism, which can vary between individuals. A doctor may prefer one over the other on those grounds, on the basis of other medicines you take, or simply because you have tolerated one well in the past.

Milligram numbers cannot be compared across the two. A 5 mg tablet of one is not a weaker version of a 50 mg tablet of the other.

The decision draws on more information than most patients realise.

That last point is worth repeating. Increasing a beta-blocker is not automatically the next step. Adding a different class at a moderate strength is often a better route, and only your doctor can weigh the two.

Every year, pharmacists meet patients who took a stronger tablet because their pressure looked high that morning, or halved a tablet because they felt tired, or borrowed a relative's strip when theirs ran out. Each of these can go wrong.

Too much beta-blockade can slow the heart dangerously, drop blood pressure, tighten breathing in someone with airway disease and hide a low blood sugar in someone with diabetes. Too little, or an interrupted course, can allow a rebound rise in heart rate and blood pressure and can bring on chest pain in people with coronary disease.

If your prescription looks different from last time, ask the pharmacist before you leave the counter. If you feel the strength is not right for you, book a review rather than experimenting. Bring your strip, your home readings and your full medicine list, and let the doctor make the change. This article is for general information only and is not a substitute for advice from a registered medical practitioner.